Literature DB >> 30538299

Lifestyle interventions in Muslim patients with metabolic syndrome-a feasibility study.

Michael F Aktas1,2, Anja Mähler1, Michael Hamm2, Gabriele Perger2, Frank Simon2, Joachim Westenhöfer2, Friedrich C Luft1, Michael Boschmann3.   

Abstract

Obesity, metabolic syndrome, and type-2 diabetes mellitus are common in Muslim patients living in Germany, most of whom are of Turkish origin. Lifestyle interventions must be tailored to religion and ethnicity. We tested the body weight-reducing effect of a 30% calorie-reduced intake diet, adjusted to individual energy expenditure, eating habits, and food preferences in a Turkish-background cohort. Eighty subjects were randomized to activity advice only or to a step-count device to monitor and document physical activity before and after the 12-week intervention. Fifty-three patients completed the study. Lifestyle interventions were effective in these Muslim subjects. Body weight was reduced by 6%; activity monitoring provided a modestly increased effect to 8%. Blood glucose, HbA1c, triglycerides and cholesterol improved also substantially. Subjects receiving metformin could reduce their dosage. Our data show that Muslim Turkish patients respond to interventions if these are tailored to their needs.

Entities:  

Year:  2018        PMID: 30538299     DOI: 10.1038/s41430-018-0371-z

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  2 in total

Review 1.  Impact of Time in Motion on Blood Pressure Regulation Among Patients with Metabolic Syndrome.

Authors:  Jennifer A Schrack; Ryan J Dougherty; Abigail Corkum; Fangyu Liu; Amal A Wanigatunga
Journal:  Curr Hypertens Rep       Date:  2022-06-13       Impact factor: 4.592

2.  Effects of the e-Motivate4Change Program on Metabolic Syndrome in Young Adults Using Health Apps and Wearable Devices: Quasi-Experimental Study.

Authors:  Ji-Soo Lee; Min-Ah Kang; Soo-Kyoung Lee
Journal:  J Med Internet Res       Date:  2020-07-30       Impact factor: 5.428

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.